|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Centers for Disease Control and Prevention, National Center for HIV, STD and TB Prevention (Dr. LoBue), Division of Tuberculosis Elimination, Field Services Branch, Atlanta, GA; and Tuberculosis Control Program (Dr. Moser), County of San Diego Health and Human Services Agency, San Diego, CA.
Correspondence to: Philip A. LoBue, MD, FCCP, Centers for Disease Control and Prevention, National Center for HIV, STD and TB Prevention, Division of Tuberculosis Elimination, Field Services and Evaluation Branch, Mail Stop E-10, 1600 Clifton Rd, Atlanta, GA 30333; e-mail: pgl5{at}cdc.gov
| Abstract |
|---|
|
|
|---|
Design: Retrospective review of computer databases and medical records.
Setting: Local public health department.
Patients: Recent immigrants and refugees classified as TB suspects in their country of departure and foreign-born patients with active TB detected through routine surveillance.
Results: Five hundred seventy-one of 658 immigrants and refugees (87%) of completed screening. Thirty-nine subjects (7%) were found to have active TB, and 433 subjects (76%) were found to have latent TB. A diagnosis of active TB was associated with age of 25 to 44 years (odds ratio, 3.6; 95% confidence interval, 1.1 to 11.6) and A (odds ratio, 25.7; 95% confidence interval, 1.3 to 512.2) or B1 classifications (odds ratio, 4.3; 95% confidence interval, 1.5 to 12.5). Cases detected through screening comprised 12% of all reported foreign-born persons with active TB. Compared to other recently arrived foreign-born persons with active TB, those detected through immigrant screening were more likely to be Asian and born in the Philippines and less likely to have advanced disease.
Conclusions: Most immigrants and refugees classified as TB suspects by foreign screening completed the US screening process, which had a high yield for detecting active and latent TB. Only a minority of foreign-born persons (12%) with active TB were discovered through this program, however, and additional measures are needed to facilitate early case finding in other foreign-born populations.
Key Words: immigrant refugee screening tuberculosis
| Introduction |
|---|
|
|
|---|
Currently, all persons attempting to enter the United States as refugees or through application for an immigrant visa must undergo a medical examination that includes screening for active TB. The TB screening process, which has been described previously, occurs in two phases: it is initiated by panel physicians (selected by the US Department of State) in the country of departure and completed in the United States by state and local health departments.3 Briefly, all immigrants and refugees at least 15 years of age are required to have a chest radiograph (CXR). Based on the CXR results, the panel physician determines if the immigrant should submit three sputum specimens for acid-fast bacilli (AFB) smear staining. Using the CXR and sputum results, the immigrant is classified as class A (active TB; infectious [AFB smear positive]); class B1 (active TB; noninfectious [AFB smear negative]); or class B2 (inactive TB) or no TB infection. Individuals with active or inactive TB are required to report to the local or state health department for further evaluation after arriving in the United States. Those with infectious TB cannot enter the United States until they have received sufficient treatment to render them noninfectious. Immigrants < 15 years of age are not required to have a CXR routinely. If such individuals have had contact with a known TB case or are suspected of having TB for other reasons, they must undergo a tuberculin skin test (TST). If there is induration or erythema of any size, a CXR is required. Additional evaluation is conducted as it is for persons > 15 years old.
In San Diego County, CA, the local TB control program conducts the US phase of the TB screening for immigrants and refugees arriving in the county who are suspected of having TB based on their overseas evaluation. To determine the yield of our screening process, we reviewed outcomes of individuals undergoing examination. Data were not available as to the total number of immigrants and refugees who began the screening process in their countries of origin; therefore, our analysis was limited to individuals suspected of having TB who were referred by the Centers for Disease Control and Prevention (CDC) Division of Global Migration and Quarantine (DGMQ), the agency that administers the immigrant and refugee health screening program. We also compared demographic and clinical characteristics of pulmonary TB cases occurring in recently arrived foreign-born persons detected through this screening with those of similar cases found through routine surveillance.
| Materials and Methods |
|---|
|
|
|---|
Panel physicians performed the mandated medical examination in the country of departure. TB notifications were classified as A, B1, or B2 according to the instructions for medical examination provided to the panel physicians by DGMQ (Table 1 ).3 Applicants have up to 6 months to enter the United States after their TB status has been designated.
|
|
To compare the characteristics of patients with active pulmonary TB identified through immigration screening with those of recent foreign-born active pulmonary TB patients discovered through routine surveillance (ie, reported to the health department by local medical providers), identical data items were extracted from the local CDC Tuberculosis Information Management System database for all other foreign-born patients with active pulmonary TB who were reported during the same time period and who had been in the United States for
1 year.
Ratios were calculated and compared in a univariate analysis using the
2 and Fisher exact tests. Multivariate logistic regression was performed to adjust for the effects of multiple explanatory variables in determining their association with one outcome of interest, specifically whether the immigrant was found to have active pulmonary TB. Explanatory variables were included in the model if they were associated with the outcome in the univariate analysis (p < 0.10). For explanatory variables with more than two categories, the category with the lowest rate of association was chosen as the reference category. Goodness of fit was adequate according to the Hosmer-Lemeshow test.4 There was no evidence of collinearity as measured by variance inflation factor analysis (< 2.5 for all independent variables).4 Associations between independent and dependent variables were considered significant at p < 0.05. Median days elapsed between foreign and US evaluations for different groups were compared using the Kruskal-Wallis test. Statistical analyses were performed using Statistical Package for the Social Sciences software (Version 11.0; SPSS; Chicago, IL).
This project was reviewed by the Office of the Associate Director of Science for the National Center for STD, HIV and TB Prevention, and considered not to be research involving human subjects. It was, therefore, not submitted to an institutional review board. To protect patient confidentiality, the database is password protected. In addition, after data were exported to SPSS for analysis, all specific identifiers (eg, name, medical record number) were removed.
| Results |
|---|
|
|
|---|
|
|
|
| Discussion |
|---|
|
|
|---|
Of the 571 immigrants and refugees screened locally, 10 subjects (2%) were found to have sputum AFB smear-positive TB. Compared to recently arrived foreign-born TB patients found through routine surveillance (ie, TB patients reported to the health department by local medical providers), patients discovered through screening tended to have less advanced disease as manifested by a lower percentage of patients with positive sputum AFB smears and cavities on CXR. A study5 conducted in California in from 1992 to 1995 had similar findings; many of the advanced, sputum AFB smear-positive cases were screened out in their country of departure, suggesting that the program was reasonably successful in this regard. Nevertheless, infectious TB cases did arrive in the United States. One possible explanation is that the patients had progression of their disease in the interval between their foreign evaluation and their arrival in San Diego. This explanation seems reasonable given that the median time elapsed between foreign and US examinations was > 5 months for sputum AFB smear-positive patients. Alternatively, specimen collection or laboratory techniques may have been suboptimal in the country of origin. Finally, one cannot exclude the possibility of intentional sputum substitution.
A number of studies have evaluated the yield of TB screening for persons immigrating to the United States. Examining cohorts of immigrants in the early 1990s, the rate of active TB was found to vary between 1% and 14%.35678 We found a rate of active TB in the middle of this range (7%). In addition to the high rate of case detection, > 75% of persons evaluated had LTBI, 60% of whom had radiographic evidence of prior TB. These findings are similar to those described for a cohort of immigrants examined in San Francisco from 1992 to 1993, and they demonstrate that new immigrant screening provides an excellent opportunity for TB prevention through LTBI treatment of a high-risk group.7 Because of their high yield for active and latent TB, immigrant-screening programs can be effective in improving TB control if recommendations for LTBI treatment are followed.9
Despite the high yield of such programs, they only detect a minority of foreign-born patients with active TB.10 In our study, 39% of pulmonary TB cases occurring in foreign-born persons residing in the United States for < 1 year (and 12% of all foreign-born pulmonary TB cases) were found through the screening process. Even more striking is the fact that only 3% of Mexican-born TB patients residing in the United States for < 1 year were discovered through immigrant screening. Given the location of San Diego on the United States/Mexico border, it is surprising that so few new immigrants from Mexico (16 total) were screened by the San Diego TB Control Program. This figure appears to be confirmed, however, by data extracted from the DGMQ database, showing that since 2001 only 23 persons immigrating from Mexico, designated as TB class A or B, listed San Diego County as their US destination (personal communication; C. Fan, CA; Department of Health Services, TB Control Branch; December 2003).
An analysis11 of foreign-born patients with TB in Tarrant County, TX, found that 59% of cases occurred in permanent residents (including legal immigrants and refugees), 25% occurred in undocumented immigrants, and 17% occurred in nonimmigrant visitors (eg, tourists, students) As in our study, these data reveal that a large fraction of reported cases among recent arrivals, especially TB occurring in tourists, students, temporary workers, and undocumented immigrants, are not detected through existing screening mechanisms, and among groups screened on entry into the United States (legal immigrants, refugees), TB reactivation more frequently occurred years after arrival. The latter cases could, in theory, be prevented if targeted tuberculin testing and LTBI treatment guidelines were followed closely and patients adhered to treatment.
Because of the gaps in the ability of current US immigrant screening practices to detect and prevent TB among foreign-born persons, additional measures have been advocated. Such measures might include the use of TST along with CXR for overseas screening of immigrants and refugees.2 This would increase the detection of LTBI in these groups, and allow for subsequent referral to local US health departments for LTBI treatment. The Institute of Medicine has also recommended TST for individuals from high TB incidence countries, already living in the United States, who are adjusting their immigration status (eg, applying for permanent residency).2 Another possible approach would be for local health departments to partner with primary medical providers to offer TB and LTBI screening and treatment for high-risk immigrants as part of routine health care. This approach can reach a wide variety of foreign-born persons, not just recent legal immigrants and refugees.
Our study has several limitations. First, approximately 12% of immigrants and refugees did not complete the screening process. This may have affected the rates of detection for active cases and latent TB. Additionally, we have no data on the number of immigrants and refugees that were screened in their country of departure, were (correctly or incorrectly) believed not to have any evidence of pulmonary TB and therefore were not referred for follow-up evaluation in the United States. The detection of some TB cases may be delayed for this reason.
In summary, we found that almost 90% of immigrants and refugees identified as high risk for TB during the initial overseas screening procedures completed the local health department TB screening process after arriving in the United States. The local screening program had a high yield for detecting active and latent TB. Immigrant and refugee screening, however, identified only a minority of TB cases in the foreign-born reported in San Diego County (12% of all foreign born cases reported and 39% of those residing in the United States for < 1 year). To maximize effectiveness, further emphasis should be placed on identifying and treating immigrants and refugees with LTBI. In addition, strategies are needed for earlier case finding in immigrants not currently screened prior to US entry.2
| Footnotes |
|---|
Funding was provided by a Centers for Disease Control and Prevention Tuberculosis Elimination Cooperative Agreement (U52/CCU900452-20).
Received for publication March 11, 2004. Accepted for publication July 13, 2004.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. A. Maloney, K. L. Fielding, K. F. Laserson, W. Jones, N. T. N. Yen, D. Q. An, N. H. Phuoc, N. A. Trinh, D. T. C. Nhung, V. T. C. Mai, et al. Assessing the Performance of Overseas Tuberculosis Screening Programs: A Study Among US-Bound Immigrants in Vietnam Arch Intern Med, January 23, 2006; 166(2): 234 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
TB Screening of Immigrants to the U.S. - Potential for Improvement Journal Watch Infectious Diseases, January 31, 2005; 2005(131): 6 - 6. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |